2006Zhongguo yaofangRequires access

Effects of Benazepril on Plasma Homocysteine Level and Blood Vessel Endothelial Function in Patients with Hypertension

Lina Zhang

Open publisher page 0 citations

Abstract

OBJECTIVE: To observe the effects of benazepril on plasma homocysteine (Hcy) level and blood vessel endothelial function in patients with essential hypertension. METHODS: A total of 77 cases were randomly divided into treatment group and control group: the control group was treated with the conventional antihypertensives, while the treatment group was treated additionally with benazepril besides antihypertensives,plasma Hcy level, brachial artery flow-mediated dilatation (FMD) function, nitrogen monoxidum (NO) level, von willber factor (vWF) level were assayed and compared before and after treatment. RESULTS: As compared with pre-treatment or the control group after treatment, the treatment group after treatment showed lower levels of Hcy and vWF, higher level of NO and significantly improved FMD(P0.001 or P0.05). CONCLUSIONS:Benazepril, an antihypertensive, could be used to lower plasma Hcy level and improve endothelial function in patients with essential hypertension.

About this research paper

What this paper is about

OBJECTIVE: To observe the effects of benazepril on plasma homocysteine (Hcy) level and blood vessel endothelial function in patients with essential hypertension. METHODS: A total of 77 cases were randomly divided into treatment group and control group: the control group was treated with the conventional antihypertensives, while the treatment group was treated additionally with benazepril besides antihypertensives,plasma Hcy level, brachial artery flow-mediated dilatation (FMD) function, nitrogen monoxidum (NO) level, von willber factor (vWF) level were assayed and compared before and after treatment. RESULTS: As compared with pre-treatment or the control group after treatment, the treatment group after treatment showed lower levels of Hcy and vWF, higher level of NO and significantly improved FMD(P0.001 or P0.05). CONCLUSIONS:Benazepril, an antihypertensive, could be used to lower plasma Hcy level and improve endothelial function in patients with essential hypertension.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To observe the effects of benazepril on plasma homocysteine (Hcy) level and blood vessel endothelial function in patients with essential hypertension. METHODS: A total of 77 cases were randomly divided into treatment group and control group: the control group was treated with the conventional antihypertensives, while the treatment group was treated additionally with benazepril besides antihypertensives,plasma Hcy level, brachial artery flow-mediated dilatation (FMD) function, nitrogen monoxidum (NO) level, von willber factor (vWF) level were assayed and compared before and after treatment. RESULTS: As compared with pre-treatment or the control group after treatment, the treatment group after treatment showed lower levels of Hcy and vWF, higher level of NO and significantly improved FMD(P0.001 or P0.05). CONCLUSIONS:Benazepril, an antihypertensive, could be used to lower plasma Hcy level and improve endothelial function in patients with essential hypertension.

Key concepts: Benazepril, Medicine, Homocysteine, Brachial artery, Internal medicine, Endothelial dysfunction, Plasma levels, Plasma homocysteine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Benazepril on Plasma Homocysteine Level and Blood Vessel Endothelial Function in Patients with Hypertension — Research Paper | ScholarLens